Research map: Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer

Back to the article

Papers in this map

  1. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome · Jérôme Galon · 2006 · 6644 citations · Cited by this paper
  2. Tumor Microenvironment Shapes Colorectal Cancer Progression, Metastasis, and Treatment Responses · Jun Li · 2022 · 89 citations · Cites this paper
  3. HBO1 suppresses anti-tumor immunity of CD8⁺ T Cells in thyroid cancer by recruiting BRD4 to regulate VTCN1 expression · 2026 · Related
  4. The consensus molecular subtypes of colorectal cancer · Justin Guinney · 2015 · 5424 citations · Cited by this paper
  5. Cancer-associated fibroblasts in colorectal cancer · Sara Kamali Zonouzi · 2021 · 85 citations · Cites this paper
  6. Conserved minimal CD8 cytotoxic immune-state unit in an IL18R1-associated immune program in hepatocellular carcinoma · 2026 · Related
  7. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies · NaNa Keum · 2019 · 2817 citations · Cited by this paper
  8. The Versatile Roles of Cancer-Associated Fibroblasts in Colorectal Cancer and Therapeutic Implications · Longfei Deng · 2021 · 50 citations · Cites this paper
  9. Impact of neck nodal yield on immune checkpoint inhibitor outcome after recurrence in head and neck squamous cell carcinoma · 2026 · Related
  10. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016 · Alessandro Lugli · 2017 · 1203 citations · Cited by this paper
  11. Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer · Charalampos Fotsitzoudis · 2022 · 47 citations · Cites this paper
  12. Preclinical efficacy of iPSC-derived MUC1-targeted CAR-NK cells against esophageal squamous cell carcinoma · 2026 · Related
  13. Tumor macrophages are pivotal constructors of tumor collagenous matrix · Ran Afik · 2016 · 391 citations · Cited by this paper
  14. Mo-MDSCs are pivotal players in colorectal cancer and may be associated with tumor recurrence after surgery · Izabela Siemińska · 2022 · 25 citations · Cites this paper
  15. Survival outcomes of conversion curative therapy following atezolizumab–bevacizumab in advanced hepatocellular carcinoma · 2026 · Related
  16. The fibrotic tumor stroma · Mitsuo Yamauchi · 2018 · 278 citations · Cited by this paper
  17. Cancer-associated fibroblasts in papillary thyroid carcinoma · Li Zhu · 2023 · 25 citations · Cites this paper
  18. Integrative single-cell and multi-omics analysis of ZBTB21-mediated serine metabolism in colorectal cancer: from metabolic reprogramming to immune microenvironment modulation · 2026 · Related
  19. The Shared and Contrasting Roles of IL2 and IL15 in the Life and Death of Normal and Neoplastic Lymphocytes: Implications for Cancer Therapy · Thomas A. Waldmann · 2015 · 244 citations · Cited by this paper
  20. The cancer-inhibitory effects of proliferating tumor-residing fibroblasts · John G. Delinassios · 2021 · 22 citations · Cites this paper
  21. Squeezing Treatment-Induced Metabolic Alterations in Melanoma Cells Are Accompanied by Impaired Cluster of Differentiation 8-Positive T Cell and Natural Killer Cell Antitumor Effector Functions · 2026 · Related
  22. Immunosuppressive activity of cancer-associated fibroblasts in head and neck squamous cell carcinoma · Hideyuki Takahashi · 2015 · 150 citations · Cited by this paper
  23. Cancer Microenvironment Defines Tumor-Infiltrating Lymphocyte Density and Tertiary Lymphoid Structure Formation in Laryngeal Cancer · Anastasia G. Gkegka · 2022 · 14 citations · Cites this paper
  24. Efficacy and safety of anti-PD-1 combined with IFN-α1b with or without anlotinib as the first-line therapy in patients with unresectable advanced melanoma: a real-world cohort study · 2026 · Related
  25. Thrombin contributes to cancer immune evasion via proteolysis of platelet-bound GARP to activate LTGF-β · Alessandra Metelli · 2020 · 141 citations · Cited by this paper
  26. Molecular mechanisms of tumour budding and its association with microenvironment in colorectal cancer · Phimmada Hatthakarnkul · 2022 · 12 citations · Cites this paper
  27. Spatially fractionated radiotherapy with PD-L1 blockade achieves superior antitumor efficacy and safety in a preclinical model of peritoneal metastasis · 2026 · Related
  28. αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion · Andrea Vannini · 2019 · 88 citations · Cited by this paper
  29. Tumor-Stroma Ratio and Programmed Cell Death Ligand 1 Expression in Preoperative Biopsy and Matched Laryngeal Carcinoma Surgical Specimen · Lara Alessandrini · 2022 · 10 citations · Cites this paper
  30. Thyroxine inhibits resveratrol-caused apoptosis by PD-L1 in ovarian cancer cells · Yu‐Tang Chin · 2018 · 58 citations · Cited by this paper
  31. Disrupting EDEM3‐induced M2‐like macrophage trafficking by glucose restriction overcomes resistance to PD‐1/PD‐L1 blockade · Shaoyong Peng · 2025 · 8 citations · Cites this paper
  32. Untitled · Cited by this paper
  33. Spatial distance between tumor and lymphocyte can predict the survival of patients with resectable lung adenocarcinoma · Xipeng Pan · 2024 · 5 citations · Cites this paper
  34. Untitled · Cited by this paper
  35. Tumor Microenvironment and Immune Response in Lip Cancer · Anastasia G. Gkegka · 2023 · 3 citations · Cites this paper
  36. Untitled · Cited by this paper
  37. Exosomal Dialogue: The Emerging Role of Cancer‐Associated Fibroblast‐Derived Exosomes in Colorectal Cancer Progression and Therapy Resistance · Ahmed M. Hjazi · 2026 · 2 citations · Cites this paper
  38. Untitled · Cited by this paper
  39. Synthetic-Based Tumor-Infiltrating Lymphocytes (TILs) in Adoptive Cell Therapies · Cornelia Amălinei · 2022 · 1 citation · Cites this paper

Source: OpenAlex (CC0)